tiprankstipranks
Trending News
More News >
Thirumalai Chemicals Limited (IN:TIRUMALCHM)
:TIRUMALCHM
India Market
Advertisement

Thirumalai Chemicals Limited (TIRUMALCHM) AI Stock Analysis

Compare
2 Followers

Top Page

IN:TIRUMALCHM

Thirumalai Chemicals Limited

(TIRUMALCHM)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - 4o)
Rating:46Neutral
Price Target:
₹272.00
▼(-1.47% Downside)
The overall stock score is primarily impacted by the company's financial challenges, including declining profitability and cash flow issues. Technical indicators also suggest a bearish trend, while valuation metrics highlight concerns with negative earnings and low dividend yield.

Thirumalai Chemicals Limited (TIRUMALCHM) vs. iShares MSCI India ETF (INDA)

Thirumalai Chemicals Limited Business Overview & Revenue Model

Company DescriptionThirumalai Chemicals Limited (TIRUMALCHM) is a leading manufacturer in the specialty chemicals sector, primarily focused on producing a diverse range of chemicals including phthalic anhydride, maleic anhydride, and other derivatives. Established in India, the company operates in multiple sectors such as textiles, plastics, and coatings, catering to both domestic and international markets. TIRUMALCHM is known for its commitment to quality and innovation, driving advancements in chemical manufacturing processes.
How the Company Makes MoneyThirumalai Chemicals Limited generates revenue through the production and sale of specialty chemicals, with key revenue streams coming from its core products like phthalic anhydride and maleic anhydride. The company benefits from a diverse customer base that spans various industries, including textiles, automotive, and construction, which helps stabilize its income amidst market fluctuations. Additionally, TIRUMALCHM may engage in long-term contracts with major clients, ensuring consistent demand for its products. Strategic partnerships with other chemical manufacturers and distributors also play a crucial role in expanding its market reach and enhancing its revenue potential.

Thirumalai Chemicals Limited Financial Statement Overview

Summary
Thirumalai Chemicals Limited faces significant financial challenges with declining revenue and profitability, increased leverage, and cash flow issues. These factors pose risks to its financial stability.
Income Statement
45
Neutral
Thirumalai Chemicals Limited experienced volatility in its income statement over the years. The company showed a declining revenue trend from 2023 to 2025, with a notable drop in profitability. The net profit margin turned negative in 2024 and 2025, indicating operational challenges. Despite a strong gross profit margin in earlier years, recent margins reflect increased cost pressures and reduced operational efficiency.
Balance Sheet
55
Neutral
The balance sheet reveals a moderate financial position. The debt-to-equity ratio has increased over the years, suggesting higher leverage and potential risk. However, the equity ratio remains relatively stable, indicating a balanced asset structure. The return on equity has declined significantly, reflecting reduced profitability and returns for shareholders.
Cash Flow
40
Negative
The cash flow statements highlight cash management issues, with negative free cash flow in recent years due to high capital expenditures. The operating cash flow has turned negative, straining liquidity and cash reserves. The negative operating cash flow to net income ratio in the latest period underscores the company's challenge in converting profits into cash.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue19.45B20.50B20.72B21.20B19.97B10.85B
Gross Profit3.90B4.63B3.87B6.01B7.65B4.16B
EBITDA150.00K488.00M645.40M2.16B4.52B2.28B
Net Income-1.11B-461.00M-387.90M898.30M2.81B1.18B
Balance Sheet
Total Assets0.0038.07B33.20B23.60B18.62B13.43B
Cash, Cash Equivalents and Short-Term Investments1.83B1.86B4.49B4.59B5.54B3.25B
Total Debt0.0017.86B12.52B5.14B1.65B1.83B
Total Liabilities-11.56B26.51B21.74B11.68B7.77B5.40B
Stockholders Equity11.56B11.56B11.46B11.92B10.85B8.03B
Cash Flow
Free Cash Flow0.00-6.79B-5.74B-3.09B3.29B1.60B
Operating Cash Flow0.00-658.80M2.37B541.30M4.02B2.21B
Investing Cash Flow0.00-5.42B-8.31B-3.59B-1.39B-1.57B
Financing Cash Flow0.003.75B6.43B2.06B-699.80M-379.70M

Thirumalai Chemicals Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price276.05
Price Trends
50DMA
292.99
Negative
100DMA
291.98
Negative
200DMA
272.64
Negative
Market Momentum
MACD
-3.98
Positive
RSI
31.94
Neutral
STOCH
17.77
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:TIRUMALCHM, the sentiment is Negative. The current price of 276.05 is below the 20-day moving average (MA) of 279.38, below the 50-day MA of 292.99, and above the 200-day MA of 272.64, indicating a bearish trend. The MACD of -3.98 indicates Positive momentum. The RSI at 31.94 is Neutral, neither overbought nor oversold. The STOCH value of 17.77 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:TIRUMALCHM.

Thirumalai Chemicals Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
₹33.22B31.891.97%-8.66%-17.79%
64
Neutral
₹12.62B38.832.50%-10.71%-40.89%
64
Neutral
₹16.00B30.600.24%10.70%32.65%
64
Neutral
₹35.66B201.060.07%16.88%0.69%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
56
Neutral
₹26.62B25.340.88%2.73%-11.40%
46
Neutral
₹28.38B0.38%-8.05%-150.62%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:TIRUMALCHM
Thirumalai Chemicals Limited
264.95
-60.70
-18.64%
IN:FCL
Fineotex Chemical Limited
26.36
-10.41
-28.30%
IN:IGPL
IG Petrochemicals Ltd.
399.35
-168.18
-29.63%
IN:IOLCP
IOL Chemicals & Pharmaceuticals Ltd.
90.62
12.97
16.71%
IN:PUNJABCHEM
Punjab Chemicals & Crop Protection Ltd.
1,272.40
206.53
19.38%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,500.25
624.72
71.35%

Thirumalai Chemicals Limited Corporate Events

Thirumalai Chemicals Announces Postal Ballot for Equity Issue
Oct 30, 2025

Thirumalai Chemicals Limited has announced the completion of dispatching the Notice of Postal Ballot to its members, as published in prominent newspapers. The company is seeking approval for a special resolution to issue equity shares through a preferential issue on a private placement basis. This move is part of the company’s strategic efforts to raise capital and enhance its financial positioning, potentially impacting its market standing and providing opportunities for investors.

Thirumalai Chemicals Seeks Shareholder Approval for Equity Issuance
Oct 29, 2025

Thirumalai Chemicals Limited has announced a postal ballot seeking shareholder approval for a special resolution to issue equity shares through a preferential issue on a private placement basis. This move is part of the company’s strategy to raise capital, potentially impacting its market positioning by enhancing its financial resources for growth and expansion.

Thirumalai Chemicals Confirms Compliance with SEBI Regulations
Oct 21, 2025

Thirumalai Chemicals Limited has submitted a confirmation certificate to the stock exchanges in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate confirms that the securities received for dematerialization during the quarter ended September 30, 2025, have been processed and listed on the relevant stock exchanges. This compliance ensures the company’s adherence to regulatory requirements, potentially strengthening its market position and maintaining trust with stakeholders.

Thirumalai Chemicals Releases Corporate Presentation for Stakeholders
Aug 17, 2025

Thirumalai Chemicals Limited has announced the release of a corporate presentation as part of its compliance with Regulation 30 of the SEBI Listing Regulations. This presentation, which will be available on the company’s website, is intended to provide stakeholders with updated information about the company’s operations and strategic direction, potentially impacting its market positioning and investor relations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 31, 2025